Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XO7Q
|
|||
| Former ID |
DIB013883
|
|||
| Drug Name |
Alequel
|
|||
| Synonyms |
Antigens (colitis), Enzo; Antigen-specific immune regulation therapy (Crohn`s), Enzo
Click to Show/Hide
|
|||
| Indication | Crohn disease [ICD-11: DD70; ICD-10: K50, K50.9; ICD-9: 555] | Phase 2 | [1] | |
| Inflammatory bowel disease [ICD-11: DD72; ICD-10: K50-K52] | Phase 1/2 | [2] | ||
| Company |
Hadassah Medical Organization
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02185183) Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.